| P2093 | author name string | Burton J | |
| | Lee L | |
| | Haber E | |
| | Bloch KJ | |
| | Hardin J | |
| | Cronlund M | |
| P2860 | cites work | Detection of intravascular coagulation | Q28364723 |
| | Measurement of fibrinopeptide A in human blood | Q34463206 |
| | An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH | Q35194006 |
| | Fibrin breakdown products and fibrinolysis in renal disease | Q36532433 |
| | Radioimmunoassay of Human Fibrinopeptide A | Q37488033 |
| | Solid-phase peptide synthesis | Q39891195 |
| | Disseminated intravascular coagulation (DIC): An approach | Q39915056 |
| | Peptides: An analytical method for their resolution by polyacrylamide gel electrophoresis applicable to a wide range of sizes and solubilities | Q40319548 |
| | Reaction of plasmic degradation products of fibrinogen in the radioimmunoassay of human fibrinopeptide A | Q44102661 |
| | Fibrinopeptide a immunoreactivity in human plasma | Q45855461 |
| | Immunologic factors and clinical activity in systemic lupus erythematosus | Q47817323 |
| | Fibrinolytic split products. A clinicopathological correlative study in adults with lupus glomerulonephritis and various renal diseases | Q47985029 |
| | The polymerization of proteins; the action of thrombin on fibrinogen. | Q51054509 |
| | Competitive inhibitors of renin. | Q52934726 |
| | Rapid calculation of radioimmunoassay results | Q53012869 |
| | Preparation of125I-labeled Native DNA for Use in Radioimmunoassays for Anti-Native-DNA Antibodies | Q54282265 |
| | Fibrinogen catabolism studies in patients with renal disease. | Q54631093 |
| | Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients | Q68347345 |
| | Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease | Q69326908 |
| | Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation | Q69377011 |
| | Split products of fibrin in human renal disease | Q70111069 |
| | Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B | Q71540111 |
| | Fibrinogen Degradation Products in Serum and Urine of Patients with Systemic Lupus Erythematosus. Relation to Renal Disease and Pathogenetic Mechanism | Q71772282 |
| | Studies of the metabolism and distribution of fibrinogen in patients with rheumatoid arthritis | Q72210846 |
| | On the primary structure of human fibrinogen. Isolation and characterization of N-terminal fragments from plasmic digests | Q72379528 |
| | Demonstration of fibrin in skin diseases. I. Lichen ruber planus and lupus erythematosus | Q93727928 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| | disseminated intravascular coagulation | Q823027 |
| P304 | page(s) | 142-151 | |
| P577 | publication date | 1976-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus | |
| P478 | volume | 58 | |